ValuationViz

HRMY fund manager activity

Harmony Biosciences Holdings, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q3 2022 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Jeremy Grantham - GMOTrimmed10,891$396,5410.00%Aug 13, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed35,866$1,305,8810.00%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Jeremy Grantham - GMOAdded11,182$313,2080.00%May 14, 2026
Joel Greenblatt - Gotham Asset ManagementAdded64,184$1,797,7940.01%May 15, 2026

Older quarters